Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Gérald Simonneau, David Montani, David S. Celermajer, Christopher P. Denton, Michael A. Gatzoulis, Michael Krowka, Paul G. Williams, Rogerio Souza

Source: Eur Respir J, 53 (1) 1801913; 10.1183/13993003.01913-2018
Journal Issue: January
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gérald Simonneau, David Montani, David S. Celermajer, Christopher P. Denton, Michael A. Gatzoulis, Michael Krowka, Paul G. Williams, Rogerio Souza. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J, 53 (1) 1801913; 10.1183/13993003.01913-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features of pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Clinical features of pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Clinical features of pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Hemodynamic and clinical relevance of “borderline pulmonary hypertension“
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
Source: Eur Respir J, 53 (1) 1801916; 10.1183/13993003.01916-2018
Year: 2019



The new definition of pulmonary hypertension
Source: Eur Respir J 2009; 34: 790-791
Year: 2009


Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis
Source: Eur Respir J, 54 (2) 1900586; 10.1183/13993003.00586-2019
Year: 2019



Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification
Source: Eur Respir J 2010; 35: 700-701
Year: 2010


Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017
Year: 2017



Pro: The current classification of pulmonary hypertension meets clinical practice
Source: Virtual Congress 2021 – The current classification of pulmonary hypertension meets clinical practice
Year: 2021


Correspondence on the debate regarding the haemodynamic definition of pulmonary hypertension
Source: Eur Respir J, 53 (6) 1900727; 10.1183/13993003.00727-2019
Year: 2019



Re-defining end-points in the assessment of pulmonary hypertension
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008


Non-invasive hemodynamic assessment in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007



The CAMbridge pulmonary hypertension outcome review (CAMPHOR): development and validation
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004

Clinical manifestations and prediction rules in patients with pulmonary embolism and prior respiratory disease
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011

Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice
Source: Eur Respir J 2013; 42: 689-700
Year: 2013



Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Clinical, functional and hemodynamic response after six months of sildenafil in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007